CVF Technologies Corporation's Holding - BIOREM Announces 3rd Order from China
December 07 2007 - 12:47PM
PR Newswire (US)
WILLIAMSVILLE, N.Y., Dec. 7 /PRNewswire-FirstCall/ -- CVF
Technologies Corporation's (OTC:CNVT) (BULLETIN BOARD: CNVT)
holding BIOREM announced the receipt of a purchase order from a
customer in Beijing, China for a Biofiltair odor control system.
This order for $280,000 (Cdn) brings 2007 bookings from China to
approximately $500,000 (Cdn) and is the third order received from
China over the past 6 months. "We are pleased that our technology
was accepted on these projects," said Peter Bruijns, President and
CEO of BIOREM. "These initial orders are a result of a committed
effort at building relationships in the region." This order brings
the current backlog to over $10.3 million (Cdn) and is part of
another strong quarter of bookings. "Our new orders to date in the
fourth quarter have already passed the $2.4 million (Cdn) mark,"
added Bruijns. BIOREM(R) (http://www.biorem.biz/) manufactures
BIOSORBENS(TM) biofilter media and is a leading supplier of
biofilters for air pollution control in municipal and industrial
applications, including the recently acquired BIOCUBE(R) modular
units. With over 400 installed systems and over a decade of
experience, the Company's biofilters are the technology of choice
for odor control at Wastewater Treatment Plants across North
America. CVF Technologies Corporation (http://www.cvfcorp.com/) is
headquartered in Williamsville, New York. CVF is a technology
development company, whose principal business is sourcing, funding
and managing emerging pre-public technology companies with
significant market potential. Founded in 1989, CVF's holdings
include four companies involved primarily in environmental
products/services. Certain statements made in this press release
which are not historical facts are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that these statements involve risks and
uncertainties, which may cause actual results or achievements to be
materially different from any future results and achievements
expressed or implied by the forward-looking statements. These risks
include, but are not limited to, product demand and market
acceptance risks for the products and technologies of CVF's
subsidiary companies and investees; the impact of competitive
products, technologies and pricing; delays or difficulties in
developing, producing, testing and selling new products and
technologies; the ability of the company's subsidiaries and
investees to obtain necessary financing for their operations and to
consummate initial public offerings of their stock; the effect of
the Company's accounting policies; the effect of trade restrictions
and other risks detailed in the company's Statement on Form 10-SB/A
filed with the U.S. Securities and Exchange Commission and any
subsequent filings with the Commission. DATASOURCE: CVF
Technologies Corporation CONTACT: Robert L. Miller, Chief Financial
Officer, +1-716-565-4711, or Jeffrey Dreben, President & CEO,
+1-716-565-4711, both of CVF Technologies Web site:
http://www.cvfcorp.com/ http://www.biorem.biz/
Copyright